Vection (ASX: VR1) climbed after securing $1.1 million in new AI and defence contracts, expanding its Dell-powered enterprise and national security footprint.
Norwest Minerals (ASX: NWM) reports strong gold recovery results and expands the Bulgera Gold Project resource to 501,000 ounces as it advances toward development.
Echo IQ secures a 6-year Mayo Clinic distribution deal for EchoSolv HF. Here’s what it means for FDA approval, AI healthcare adoption, and future revenue potential.
Pan African Resources plans to acquire Emmerson Resources in a $311 million takeover, offering a 42.7% premium. The deal consolidates the Tennant Creek gold region in Australia.
AusQuest shares trade near $0.45 as drilling expands the Cangallo copper system in Peru to 1.5 km strike and 400 m depth with heap leach potential.
Arika reports 21m at 4.65g/t gold in deepest drill hole at Laverton project. Shares rise as strike extends to 350m with mineralisation open.
Altair Minerals reveals thick high-grade gold intercepts at Greater Oko in Guyana, defining three large-scale targets and setting up an active 2026 drilling campaign.
European Metals Holdings (ASX: EMH) secures up to €360m from the Czech Government for its Cinovec Lithium Project, marking a major milestone in EU supply-chain strategy. Full details, commentary and project insights.
Recce Pharmaceuticals (ASX:RCE) wins Family 4 patent in Hong Kong for RECCE® 327 and 529, expanding IP across Asia as Phase 3 trials continue in Indonesia. CEO James Graham explains the strategic importance and next steps.
Eclipse Metals (ASX: EPM) appoints a US strategic advisor for government relations while fieldwork and new geophysical modelling at Ivigtuut and Gronnedal highlight uranium and rare earth element potential in Greenland.
Cauldron Energy (ASX: CXU) reports a major uranium discovery at Manyingee North, with thick high-grade intersections across all first drillholes. Mineralisation remains open, marking Yanrey as one of Australia’s most prospective uranium regions.
Infini Resources (ASX: I88) reports visible uranium and strong polymetallic signatures across multiple drill holes at Portland Creek. CEO Rohan Bone says results “surpass expectations” as the project evolves into a compelling early-stage uranium system.
Vection (ASX: VR1) climbed after securing $1.1 million in new AI and defence contracts, expanding its Dell-powered enterprise and national security footprint.
Norwest Minerals (ASX: NWM) reports strong gold recovery results and expands the Bulgera Gold Project resource to 501,000 ounces as it advances toward development.
Echo IQ secures a 6-year Mayo Clinic distribution deal for EchoSolv HF. Here’s what it means for FDA approval, AI healthcare adoption, and future revenue potential.
European Lithium plans to acquire US based titanium producer Velta in an all scrip deal, diversifying beyond lithium into critical materials for defence, aerospace and advanced manufacturing.
Life360 reports record Q4 2025 MAUs of 95.8m and Paying Circles of 2.8m, lifting FY2025 revenue and adjusted EBITDA guidance and targeting 20% MAU growth in 2026.
Zelira Therapeutics (ASX:ZLD) jumps after announcing a US$32.98m raise into its HOPE 1 SPV, valuing the vehicle at US$65.96m post money and funding FDA trial plans in PMS linked autism.
.webp&w=3840&q=75)
Cleo Diagnostics (ASX:COV) gains U.S. approval to access PLCO biobank, enhancing its ovarian cancer test’s FDA submission. Shares rise 8.82% as pivotal trials ramp up for Q4 2025 finish.
Sparc Technologies (ASX: SPN) opens its groundbreaking photocatalytic hydrogen pilot plant in South Australia, targeting scalable, low-cost green hydrogen production without electrolysers.
Provaris Energy (ASX: PV1) jumps 40% after signing a landmark MOU with shipping giant K LINE to develop hydrogen carriers. Learn how this deal boosts Europe’s hydrogen import ambitions.
AML3D (ASX: AL3) launches a new facility in Ohio to support the U.S. Navy’s submarine program and AUKUS alliance. Stock jumps 7.4% on expansion news.
Noronex (ASX: NRX) has begun a spectrometry survey at its Etango North Uranium Project in Namibia, leveraging AI to pinpoint drill targets. Shares rise on uranium momentum.
Aurum Resources (ASX: AUE) begins Phase 2 drilling at Boundiali Gold Project, targeting maiden JORC Resource by 2025. Read the latest update here.
BluGlass (ASX: BLG) lands $230K order from India’s Ministry of Defence for GaN lasers. Shares soar 16.67% as strategic photonics capabilities gain traction.
Brookside Energy (ASX: BRK) achieves first oil and gas sales from Bruins Well in Oklahoma. Delivered in just 14 weeks, the well strengthens BRK’s SWISH production base.
RareX (ASX: REE) partners with Gega Elements to develop Australia’s first integrated gallium supply chain, leveraging critical minerals from Cummins Range and Khaleesi Projects.
Cobalt Blue shares jump 20.7% as Glencore advances its option on the Broken Hill Cobalt Project (BHCP). The deal marks a pivotal step in Australia’s critical minerals strategy.
ReNerve Ltd (ASX:RNV) secures Bahrain approval for its innovative NervAlign® Nerve Cuff™, marking a key milestone in global expansion. Shares up 9.5% as Middle East market opens up.
Prescient Therapeutics (ASX: PTX) has dosed the first patient in its Phase 2a trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma. The study aims to enrol 40 patients across Australia, the USA, and Europe.
%252520hits%252520high%252520grade%252520at%252520Lydia.webp&w=3840&q=75)
%252520Strikes%252520Bonanza%25252047%252520%252520Antimony%252520at%252520Sunday%252520Creek%252520as%252520Critical%252520Minerals%252520Story%252520Gains%252520Momentum.webp&w=3840&q=75)